Vanessa Sue Wacleche, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Th17 Cells | 5 | 2017 | 766 | 0.980 |
Why?
|
| Receptors, CCR6 | 6 | 2017 | 81 | 0.900 |
Why?
|
| Monocytes | 4 | 2021 | 2593 | 0.800 |
Why?
|
| Receptors, IgG | 3 | 2021 | 581 | 0.730 |
Why?
|
| Dendritic Cells | 4 | 2021 | 2720 | 0.680 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2022 | 985 | 0.670 |
Why?
|
| Retinal Dehydrogenase | 1 | 2018 | 74 | 0.660 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 96 | 0.640 |
Why?
|
| HIV-1 | 9 | 2018 | 6939 | 0.600 |
Why?
|
| Research Personnel | 1 | 2022 | 573 | 0.590 |
Why?
|
| Tretinoin | 3 | 2021 | 517 | 0.510 |
Why?
|
| Integrin beta Chains | 2 | 2012 | 121 | 0.500 |
Why?
|
| HIV Infections | 10 | 2021 | 16715 | 0.460 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2021 | 4386 | 0.400 |
Why?
|
| Receptors, CCR4 | 4 | 2016 | 81 | 0.370 |
Why?
|
| Autoimmunity | 1 | 2017 | 1349 | 0.350 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2016 | 1872 | 0.320 |
Why?
|
| Antigens, CD | 1 | 2018 | 4026 | 0.310 |
Why?
|
| Receptors, CXCR3 | 3 | 2016 | 237 | 0.310 |
Why?
|
| Homeostasis | 1 | 2017 | 3337 | 0.280 |
Why?
|
| Interleukins | 2 | 2022 | 791 | 0.270 |
Why?
|
| Virus Replication | 5 | 2016 | 2535 | 0.250 |
Why?
|
| Receptors, CXCR5 | 2 | 2022 | 92 | 0.250 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7719 | 0.240 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2017 | 1837 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2012 | 4221 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2019 | 71 | 0.180 |
Why?
|
| Synovial Membrane | 1 | 2022 | 506 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 4477 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 4665 | 0.150 |
Why?
|
| Immunity, Mucosal | 2 | 2017 | 490 | 0.150 |
Why?
|
| Interleukin-17 | 3 | 2017 | 902 | 0.130 |
Why?
|
| Immunologic Memory | 3 | 2016 | 1347 | 0.120 |
Why?
|
| Blood | 1 | 2017 | 596 | 0.120 |
Why?
|
| Chemokines | 1 | 2018 | 968 | 0.120 |
Why?
|
| Th1 Cells | 3 | 2015 | 1057 | 0.120 |
Why?
|
| Antigen-Presenting Cells | 1 | 2018 | 972 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 1836 | 0.120 |
Why?
|
| Keratolytic Agents | 1 | 2012 | 31 | 0.110 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1602 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2018 | 1283 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 814 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2217 | 0.100 |
Why?
|
| Anti-Retroviral Agents | 3 | 2017 | 1714 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2013 | 492 | 0.090 |
Why?
|
| Colon | 1 | 2017 | 1772 | 0.080 |
Why?
|
| Neoplasms | 1 | 2017 | 21675 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 9440 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2019 | 2104 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2015 | 2540 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3712 | 0.070 |
Why?
|
| Humans | 15 | 2022 | 743811 | 0.060 |
Why?
|
| Macrophages | 2 | 2018 | 5651 | 0.060 |
Why?
|
| Immunophenotyping | 1 | 2009 | 1880 | 0.060 |
Why?
|
| Flow Cytometry | 4 | 2019 | 5973 | 0.060 |
Why?
|
| HIV | 1 | 2012 | 1604 | 0.060 |
Why?
|
| Cytokines | 1 | 2018 | 7324 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 13980 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2018 | 3750 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2015 | 11478 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 435 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 2019 | 19232 | 0.040 |
Why?
|
| Listeria monocytogenes | 1 | 2021 | 250 | 0.040 |
Why?
|
| Fungi | 1 | 2021 | 326 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 25032 | 0.040 |
Why?
|
| DNA, Viral | 2 | 2017 | 2226 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 807 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2015 | 5 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 4 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 1342 | 0.030 |
Why?
|
| Animals | 2 | 2018 | 168660 | 0.030 |
Why?
|
| Virus Activation | 1 | 2017 | 319 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6170 | 0.030 |
Why?
|
| Cell Separation | 1 | 2019 | 1750 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 1453 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2013 | 364 | 0.030 |
Why?
|
| Cell Communication | 1 | 2019 | 1621 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1677 | 0.030 |
Why?
|
| Integrin alpha4 | 1 | 2011 | 92 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 81154 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 498 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 2500 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2009 | 1061 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 213889 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 2560 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56392 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 1781 | 0.010 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 1479 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21733 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4204 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 213241 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3917 | 0.010 |
Why?
|
| Male | 4 | 2021 | 349776 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9139 | 0.010 |
Why?
|
| Female | 4 | 2021 | 380020 | 0.010 |
Why?
|
| RNA | 1 | 2009 | 2748 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 2961 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 163178 | 0.010 |
Why?
|